Rose Edmonds
Impact in
-
- Retinal Diseases and Treatments
-
- Cutaneous lymphoproliferative disorders research
Papers in
-
- Retinal Diseases and Treatments 3
- Glaucoma and retinal disorders 1
-
- Renal cell carcinoma treatment 1
- Gastric Cancer Management and Outcomes 1
- Co-authors
- Michael Chang (2 shared papers)Lee Honigberg (3 shared papers)Neha Didwaniya (2 shared papers)Peter T. Silberstein (2 shared papers)Suki Subbiah (1 shared paper)Xiang Fang (1 shared paper)Anne Biever (1 shared paper)Johnny Gutierrez (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Investigative Ophthalmology & Visual Science (1 paper)Journal of Alzheimer s Disease (1 paper)Ophthalmology Science (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Rose Edmonds
6 papers receiving 23 citations
Peers
Comparison fields: 5 of 18
- Ophthalmology 10
- Dermatology 3
- Immunology 4
- Biophysics 1
- Nephrology 1
Countries citing papers authored by Rose Edmonds
This map shows the geographic impact of Rose Edmonds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Edmonds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Edmonds more than expected).
Fields of papers citing papers by Rose Edmonds
This network shows the impact of papers produced by Rose Edmonds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Edmonds. The network helps show where Rose Edmonds may publish in the future.
Co-authors
The 11 scholars most cited alongside Rose Edmonds, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2011 | 5 | |
| 3 | 2023 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2011 | 2 | |
| 6 | Lampalizumab inhibits ocular alternative complement activity in patients with geographic atrophy secondary to age-related macular degeneration | 2020 | 1 |
About Rose Edmonds
Rose Edmonds is a scholar working on Ophthalmology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Oncology, having authored 6 papers that have together received 25 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (3 papers), Glaucoma and retinal disorders (1 paper), Retinal Imaging and Analysis (1 paper), Helicobacter pylori-related gastroenterology studies (1 paper), Renal cell carcinoma treatment (1 paper), Gastric Cancer Management and Outcomes (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper) and Renal and related cancers (1 paper). The work is most often cited by research in Ophthalmology (10 citations), Dermatology (3 citations), Immunology (4 citations), Biophysics (1 citation) and Nephrology (1 citation). Rose Edmonds has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Michael Chang, Lee Honigberg, Neha Didwaniya, Peter T. Silberstein, Suki Subbiah, Xiang Fang, Anne Biever, Johnny Gutierrez, Robert Perneczky and Carolin Kurz. Their work appears in journals such as Journal of Clinical Oncology, Investigative Ophthalmology & Visual Science, Journal of Alzheimer s Disease and Ophthalmology Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.